Kayvan Tehrani, an optical engineer and researcher, is the founder of Eleuthra Photonics, specializing in nonlinear optics histopathology. With an extensive background in physics and engineering and recognized by an NIH fellowship, Kayvan's research focuses on enhancing microscopy, label-free tissue analysis, and discovering new optical biomarkers for diseases such as cancer and Alzheimer's. His entrepreneurial pursuit is dedicated to advancing digital histopathology through the creation of a groundbreaking imaging tool engineered for swift, label-free examination of tissue samples. This innovative technology promises to significantly reduce diagnostic turnaround times from days to minutes, enhancing both the speed and accuracy of cancer diagnostics.This cutting-edge technology mitigates potential diagnostic errors associated with conventional histopathological techniques and data interpretation methods by eliminating the necessity for chemical stains and furnishing multi-dimensional quantitative datasets. This expedites the diagnostic process and augments the precision of cancer diagnoses, thereby facilitating the development of more tailored and efficient treatment plans for patients.